Cargando…
PPARdelta in Affected Atopic Dermatitis and Psoriasis: A Possible Role in Metabolic Reprograming
Peroxisome proliferator-activated receptors (PPARs) are nuclear hormone receptors expressed in the skin. Three PPAR isotypes, α (NRC1C1), β or δ (NRC1C2) and γ (NRC1C3), have been identified. After activation through ligand binding, PPARs heterodimerize with the 9-cis-retinoic acid receptor (RXR), a...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8303290/ https://www.ncbi.nlm.nih.gov/pubmed/34298981 http://dx.doi.org/10.3390/ijms22147354 |
_version_ | 1783727051388223488 |
---|---|
author | Blunder, Stefan Pavel, Petra Minzaghi, Deborah Dubrac, Sandrine |
author_facet | Blunder, Stefan Pavel, Petra Minzaghi, Deborah Dubrac, Sandrine |
author_sort | Blunder, Stefan |
collection | PubMed |
description | Peroxisome proliferator-activated receptors (PPARs) are nuclear hormone receptors expressed in the skin. Three PPAR isotypes, α (NRC1C1), β or δ (NRC1C2) and γ (NRC1C3), have been identified. After activation through ligand binding, PPARs heterodimerize with the 9-cis-retinoic acid receptor (RXR), another nuclear hormone receptor, to bind to specific PPAR-responsive elements in regulatory regions of target genes mainly involved in organogenesis, cell proliferation, cell differentiation, inflammation and metabolism of lipids or carbohydrates. Endogenous PPAR ligands are fatty acids and fatty acid metabolites. In past years, much emphasis has been given to PPARα and γ in skin diseases. PPARβ/δ is the least studied PPAR family member in the skin despite its key role in several important pathways regulating inflammation, keratinocyte proliferation and differentiation, metabolism and the oxidative stress response. This review focuses on the role of PPARβ/δ in keratinocytes and its involvement in psoriasis and atopic dermatitis. Moreover, the relevance of targeting PPARβ/δ to alleviate skin inflammation is discussed. |
format | Online Article Text |
id | pubmed-8303290 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-83032902021-07-25 PPARdelta in Affected Atopic Dermatitis and Psoriasis: A Possible Role in Metabolic Reprograming Blunder, Stefan Pavel, Petra Minzaghi, Deborah Dubrac, Sandrine Int J Mol Sci Review Peroxisome proliferator-activated receptors (PPARs) are nuclear hormone receptors expressed in the skin. Three PPAR isotypes, α (NRC1C1), β or δ (NRC1C2) and γ (NRC1C3), have been identified. After activation through ligand binding, PPARs heterodimerize with the 9-cis-retinoic acid receptor (RXR), another nuclear hormone receptor, to bind to specific PPAR-responsive elements in regulatory regions of target genes mainly involved in organogenesis, cell proliferation, cell differentiation, inflammation and metabolism of lipids or carbohydrates. Endogenous PPAR ligands are fatty acids and fatty acid metabolites. In past years, much emphasis has been given to PPARα and γ in skin diseases. PPARβ/δ is the least studied PPAR family member in the skin despite its key role in several important pathways regulating inflammation, keratinocyte proliferation and differentiation, metabolism and the oxidative stress response. This review focuses on the role of PPARβ/δ in keratinocytes and its involvement in psoriasis and atopic dermatitis. Moreover, the relevance of targeting PPARβ/δ to alleviate skin inflammation is discussed. MDPI 2021-07-08 /pmc/articles/PMC8303290/ /pubmed/34298981 http://dx.doi.org/10.3390/ijms22147354 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Blunder, Stefan Pavel, Petra Minzaghi, Deborah Dubrac, Sandrine PPARdelta in Affected Atopic Dermatitis and Psoriasis: A Possible Role in Metabolic Reprograming |
title | PPARdelta in Affected Atopic Dermatitis and Psoriasis: A Possible Role in Metabolic Reprograming |
title_full | PPARdelta in Affected Atopic Dermatitis and Psoriasis: A Possible Role in Metabolic Reprograming |
title_fullStr | PPARdelta in Affected Atopic Dermatitis and Psoriasis: A Possible Role in Metabolic Reprograming |
title_full_unstemmed | PPARdelta in Affected Atopic Dermatitis and Psoriasis: A Possible Role in Metabolic Reprograming |
title_short | PPARdelta in Affected Atopic Dermatitis and Psoriasis: A Possible Role in Metabolic Reprograming |
title_sort | ppardelta in affected atopic dermatitis and psoriasis: a possible role in metabolic reprograming |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8303290/ https://www.ncbi.nlm.nih.gov/pubmed/34298981 http://dx.doi.org/10.3390/ijms22147354 |
work_keys_str_mv | AT blunderstefan ppardeltainaffectedatopicdermatitisandpsoriasisapossibleroleinmetabolicreprograming AT pavelpetra ppardeltainaffectedatopicdermatitisandpsoriasisapossibleroleinmetabolicreprograming AT minzaghideborah ppardeltainaffectedatopicdermatitisandpsoriasisapossibleroleinmetabolicreprograming AT dubracsandrine ppardeltainaffectedatopicdermatitisandpsoriasisapossibleroleinmetabolicreprograming |